United States Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
September 17, 2014
122 Pages - SKU: BMI5329158
Countries covered: United States

United States Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The US pharmaceutical market presents strong commercial opportunities across the industry.Total US pharmaceutical sales reached USD347.2bn in 2013 - more than three times the size of its nearestrival Japan. The US boasts the largest individual markets across the three core sub-sectors: patented, genericand over-the-counter medicines. State-level pharmaceutical markets in the country are larger than manycountry-level pharmaceutical markets.

Headline Expenditure Projections

Pharmaceuticals: USD347.2bn in 2013 to USD352.8bn in 2014; 1.6% growth in local currency terms.Forecast unchanged from Q314.

Healthcare: USD2,918bn in 2013 to USD3,112bn in 2014; +6.7% growth in local currency terms.Forecast unchanged from Q314.



More Manufacturing, Packaging & Detailing reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More United States Manufacturing, Packaging & Detailing reports

Pharmaceutical Manufacturing by First Research, Inc.
Pharmaceutical ManufacturingBrief Excerpt from Industry Overview Chapter:Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, ...
Biotechnology Product Manufacturing by First Research, Inc.
Biotechnology Product ManufacturingBrief Excerpt from Industry Overview Chapter:Companies in this industry manufacture drugs, therapies, vaccines, genetically modified food and fuel, and other products based on ...
PharmaPoint: Asthma - US Drug Forecast and Market Analysis to 2023 by GlobalData
PharmaPoint: Asthma - US Drug Forecast and Market Analysis to 2023SummaryAsthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be ...
Scientific Research and Development (R&D) Industry, in Telecommunications, Computers, Physical Sciences, Medical Devices and Pharmaceuticals Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541700 by Plunkett Research, Ltd.
Scientific Research and Development (R&D) Industry, in Telecommunications, Computers, Physical Sciences, Medical Devices and Pharmaceuticals Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!